Tesla’s 38% Revenue Miss Sends Shockwaves Through Markets
724FinanceBora Yalın
Key Highlights
Tesla, ikinci çeyrek 2026 sonuçlarını açıklarken, beklenen gelirin **%38** altında kalması ve net kârda büyük bir düşüşle yatırımcılara sürpriz yaptı.
Tesla surprised investors with its Q2 2026 results, posting revenue 38% below expectations and a steep earnings decline.
Tesla’s 38% Revenue Shortfall Rocks the Markets
The automaker reported $28.24 billion in Q2 revenue, yet earnings fell to $0.33 per share versus consensus $0.53, triggering a 14% single‑day drop in the stock price.
Profit Margins and Cash Flow: The Anatomy of the Decline
Growth Engines Beyond Cars: Robotaxi, Optimus, and AI
Tesla is betting on new verticals—Robotaxi services, the Optimus humanoid robot, and AI compute infrastructure—to cement its role as a full‑stack autonomous technology and energy platform.
Market Reaction and Valuation Gap
Bora Yalın – Tesla’s near‑term earnings pressure, combined with global liquidity tightening and a risk‑off backdrop, could amplify stock volatility. Yet its long‑term growth pillars—robotaxi, AI, and energy storage—still present an attractive risk‑on play, offering low‑correlation exposure in diversified portfolios.
Related News & Analysis
View All →
Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout

Singh Joins Mayfield: A New Era for Chip Investments

Ramp Unveils Model Router, Steering the AI Landscape into a New Era

WNBA’s Landmark Pay Raise: 364% Surge in Player Wages Sparks Labor Milestone

Gen Z Rewrites the American Dream in the Great Postponement

Inertia Enterprises Cuts Fusion Fuel Loading to Hours, Shaking the Energy Market
Latest Market News
All News →![[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş.
Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş. Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu

Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout
Moderna’s Personalized mRNA Gamble: Oncology Revolution or Market Bubble?
![[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş.
Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş. Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında

Norway’s July Oil Production Slump Sends Shockwaves Through European Energy Markets
